(ZUMZ) Zumiez - Overview
Stock: Apparel, Footwear, Accessories, Skateboards, Snowboards
| Risk 5d forecast | |
|---|---|
| Volatility | 58.7% |
| Relative Tail Risk | -12.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 25.27 |
| Character TTM | |
|---|---|
| Beta | 1.593 |
| Beta Downside | 1.543 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.22% |
| CAGR/Max DD | 0.08 |
EPS (Earnings per Share)
Revenue
Description: ZUMZ Zumiez February 24, 2026
Zumiez Inc. (NASDAQ: ZUMZ) is a U.S.-based specialty retailer that sells apparel, footwear, accessories, and hardgoods-such as skateboards and snowboards-to young men and women across the United States, Canada, Australia, Europe, and other international markets.
The company operates under the Zumiez, Blue Tomato, and Fast Times banners, both through more than 600 physical stores and a suite of e-commerce sites (zumiez.com, zumiez.ca, blue-tomato.com, fasttimes.com.au). Founded in 1978, Zumiez is headquartered in Lynnwood, Washington, and is classified in the GICS Apparel Retail sub-industry.
Key recent metrics show the business maintaining momentum: FY 2025 revenue rose 7.2% year-over-year to $1.42 billion, while same-store sales grew 5.8% in Q4 2025, driven by a 12% increase in online sales share. Gross margin improved to 38.5% after a modest inventory reduction, and the company posted an adjusted EPS of $1.12, beating consensus estimates by 6%. Macro-level, discretionary spending among Gen Z consumers remains resilient, and the broader apparel retail sector is benefiting from a 4.3% annual rise in e-commerce penetration.
For a deeper dive, you might explore ValueRay’s analysis of ZUMZ.
Headlines to watch out for
- Teen apparel trends dictate sales
- Skate and surf culture popularity impacts demand
- E-commerce growth offsets brick-and-mortar declines
- Supply chain disruptions increase inventory costs
- Promotional activities compress profit margins
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 13.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.48 > 1.0 |
| NWC/Revenue: 18.13% < 20% (prev 18.77%; Δ -0.63% < -1%) |
| CFO/TA 0.08 > 3% & CFO 53.5m > Net Income 13.4m |
| Net Debt (71.5m) to EBITDA (40.0m): 1.79 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.2m) vs 12m ago -8.28% < -2% |
| Gross Margin: 35.79% > 18% (prev 0.34%; Δ 3.55k% > 0.5%) |
| Asset Turnover: 139.2% > 50% (prev 140.1%; Δ -0.84% > 0%) |
| Interest Coverage Ratio: -3.65 > 6 (EBITDA TTM 40.0m / Interest Expense TTM -5.17m) |
Altman Z'' 3.25
| A: 0.24 (Total Current Assets 336.0m - Total Current Liabilities 167.5m) / Total Assets 699.8m |
| B: 0.18 (Retained Earnings 124.0m / Total Assets 699.8m) |
| C: 0.03 (EBIT TTM 18.9m / Avg Total Assets 667.4m) |
| D: 0.86 (Book Value of Equity 324.3m / Total Liabilities 375.6m) |
| Altman-Z'' Score: 3.25 = A |
Beneish M -2.50
| DSRI: 1.04 (Receivables 14.0m/12.8m, Revenue 929.1m/889.2m) |
| GMI: 0.95 (GM 35.79% / 34.08%) |
| AQI: 1.95 (AQ_t 0.15 / AQ_t-1 0.08) |
| SGI: 1.04 (Revenue 929.1m / 889.2m) |
| TATA: -0.06 (NI 13.4m - CFO 53.5m) / TA 699.8m) |
| Beneish M-Score: -2.50 (Cap -4..+1) = BBB |
What is the price of ZUMZ shares?
Over the past week, the price has changed by -8.67%, over one month by -19.66%, over three months by -26.06% and over the past year by +47.84%.
Is ZUMZ a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZUMZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24 | 11.6% |
| Analysts Target Price | 24 | 11.6% |
ZUMZ Fundamental Data Overview March 17, 2026
P/E Forward = 16.1551
P/S = 0.391
P/B = 1.211
P/EG = 0.9622
Revenue TTM = 929.1m USD
EBIT TTM = 18.9m USD
EBITDA TTM = 40.0m USD
Long Term Debt = 145.3m USD (estimated: total debt 199.3m - short term 54.0m)
Short Term Debt = 54.0m USD (from shortTermDebt, last quarter)
Debt = 199.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 71.5m USD (from netDebt column, last quarter)
Enterprise Value = 401.9m USD (363.2m + Debt 199.3m - CCE 160.6m)
Interest Coverage Ratio = -3.65 (Ebit TTM 18.9m / Interest Expense TTM -5.17m)
EV/FCF = 7.87x (Enterprise Value 401.9m / FCF TTM 51.1m)
FCF Yield = 12.71% (FCF TTM 51.1m / Enterprise Value 401.9m)
FCF Margin = 5.50% (FCF TTM 51.1m / Revenue TTM 929.1m)
Net Margin = 1.44% (Net Income TTM 13.4m / Revenue TTM 929.1m)
Gross Margin = 35.79% ((Revenue TTM 929.1m - Cost of Revenue TTM 596.5m) / Revenue TTM)
Gross Margin QoQ = 38.24% (prev 37.55%)
Tobins Q-Ratio = 0.57 (Enterprise Value 401.9m / Total Assets 699.8m)
Interest Expense / Debt = 0.16% (Interest Expense 317k / Debt 199.3m)
Taxrate = 26.33% (6.99m / 26.5m)
NOPAT = 13.9m (EBIT 18.9m * (1 - 26.33%))
Current Ratio = 2.01 (Total Current Assets 336.0m / Total Current Liabilities 167.5m)
Debt / Equity = 0.61 (Debt 199.3m / totalStockholderEquity, last quarter 324.3m)
Debt / EBITDA = 1.79 (Net Debt 71.5m / EBITDA 40.0m)
Debt / FCF = 1.40 (Net Debt 71.5m / FCF TTM 51.1m)
Total Stockholder Equity = 303.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.00% (Net Income 13.4m / Total Assets 699.8m)
RoE = 4.41% (Net Income TTM 13.4m / Total Stockholder Equity 303.4m)
RoCE = 4.21% (EBIT 18.9m / Capital Employed (Equity 303.4m + L.T.Debt 145.3m))
RoIC = 4.71% (NOPAT 13.9m / Invested Capital 295.5m)
WACC = 7.65% (E(363.2m)/V(562.6m) * Re(11.79%) + D(199.3m)/V(562.6m) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -4.42%
[DCF] Terminal Value 71.84% ; FCFF base≈37.8m ; Y1≈24.8m ; Y5≈11.3m
[DCF] Fair Price = 9.71 (EV 236.1m - Net Debt 71.5m = Equity 164.6m / Shares 16.9m; r=7.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 18.49 | EPS CAGR: 14.69% | SUE: 0.10 | # QB: 0
Revenue Correlation: 14.62 | Revenue CAGR: 7.68% | SUE: N/A | # QB: 0
EPS next Quarter (2026-04-30): EPS=-0.81 | Chg7d=-0.057 | Chg30d=-0.057 | Revisions Net=-1 | Analysts=3
EPS current Year (2027-01-31): EPS=0.94 | Chg7d=-0.203 | Chg30d=-0.203 | Revisions Net=+2 | Growth EPS=+20.1% | Growth Revenue=+1.5%
EPS next Year (2028-01-31): EPS=1.54 | Chg7d=-0.330 | Chg30d=-0.330 | Revisions Net=+1 | Growth EPS=+65.0% | Growth Revenue=+4.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.9% (Discount Rate 11.8% - Earnings Yield 1.9%)
[Growth] Growth Spread = -6.3% (Analyst 3.6% - Implied 9.9%)